Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

Autor: Milton Packer, MD*; John J.V. McMurray, MD*; Akshay S. Desai, MD, MPH; Jianjian Gong, PhD; Martin P. Lefkowitz, MD; Adel R. Rizkala, PharmD; Jean L. Rouleau, MD; et al.
26 de diciembre de 2014